
The longevity market is growing faster than credible clinics can enter it. ACG has launched 350+ clinics across 46 states — including NAD+, healthspan, and longevity clinics from the category's earliest days.
Book a Strategy CallAnti-aging has been rebranded as longevity — and the market responded. The U.S. longevity clinic market reached $23.5 billion and was named the hottest healthcare trend of 2025. That is not hype. That is documented consumer behavior.
In most U.S. markets the consumer demand arrived before the supply. The clinic that opens now, positioned correctly, captures share that takes years to displace.
The longevity patient isn't looking for the cheapest option. They're looking for the clinic that understands what they're trying to build — and can help them build it.
Representative of broader category trends. Local demand varies by market.
The business is built around protocols, not one-time visits — and that structure creates recurring revenue. A longevity patient who joins a membership in January is still enrolled in December and referring their spouse by March.
IV and intramuscular NAD+ for cellular energy decline and the biological aging process. The flagship longevity-context modality. For NAD+ in cognitive and neuroinflammation applications, see Neurological Wellness; for NAD+ as a premium IV-bar menu tier, see IV Therapy & Infusion.
Longevity-anchored peptide protocols supporting healthspan, cellular regeneration, and biological aging markers. Compound selection is patient-specific and Medical-Director-led. For specialized applications — peptides paired with TRT, peptides for joint recovery, or a standalone peptide-first clinic — see our Men's Health & TRT, Joint & Musculoskeletal, or Peptide Therapy pages.
Photobiomodulation for cellular repair and inflammation. Low overhead, recurring session model.
Topical exosome facials, microneedling-applied PRP, and collagen-stimulating protocols for skin aging — a longevity-clinic aesthetic offering. For dedicated aesthetic clinics covering Botox, dermal fillers, and full med spa services, see our Aesthetics page.
Lab panels, biological age testing, and functional health tracking that justify protocol continuity.
Monthly and quarterly tiers that bundle protocols, labs, and check-ins into predictable recurring revenue.
Longevity clinics have specific requirements that generic consulting doesn't account for — NAD+ infusion protocols, peptide supplier vetting, compounding pharmacy compliance, and the positioning decisions that determine whether a clinic attracts premium patients or competes on price. ACG has navigated every piece of this across hundreds of launches.
Location intelligence, demographic mapping, competitive audit. You know whether the opportunity exists before committing capital.
Entity structure, state licensing, Medical Director introduction. ACG coordinates the clinical infrastructure.
Pre-negotiated access to NAD+, peptide, and red light suppliers at preferred rates. Protocols in place before your first patient.
ACG's marketing infrastructure attracts premium patients from day one — not bargain hunters.
60 days of continued support — patient flow, marketing optimization, operational refinement.
The protocols are not the differentiator. The clinic identity is. ACG builds longevity clinics with brand identities — because the patient who feels genuinely understood doesn't shop around.
A services list. Competes on price. Loses to whoever opens cheaper nearby.
A clear patient identity. Attracts the right patient. Charges a premium. Builds referrals.
The branded clinic survives saturation. The protocol-only clinic doesn't.
Book a free strategy call. ACG will walk you through the longevity opportunity in your specific market — the compliance picture, the supplier access, and what the process looks like from first conversation to open doors.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time